Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys.
Diabetes
NCD
Screening
Smoking: tobacco
TB
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
27
02
2023
revised:
24
07
2023
accepted:
16
08
2023
medline:
8
9
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
epublish
Résumé
Non-communicable diseases (NCDs) and NCD risk factors, such as smoking, increase the risk for tuberculosis (TB). Data are scarce on the risk of prevalent TB associated with these factors in the context of population-wide systematic screening and on the association between NCDs and NCD risk factors with different manifestations of TB, where ∼50% being asymptomatic but bacteriologically positive (subclinical). We did an individual participant data (IPD) meta-analysis of national and sub-national TB prevalence surveys to synthesise the evidence on the risk of symptomatic and subclinical TB in people with NCDs or risk factors, which could help countries to plan screening activities. In this systematic review and IPD meta-analysis, we identified eligible prevalence surveys in low-income and middle-income countries that reported at least one NCD (e.g., diabetes) or NCD risk factor (e.g., smoking, alcohol use) through the archive maintained by the World Health Organization and by searching in Medline and Embase from January 1, 2000 to August 10, 2021. The search was updated on March 23, 2023. We performed a one-stage meta-analysis using multivariable multinomial models. We estimated the proportion of and the odds ratio for subclinical and symptomatic TB compared to people without TB for current smoking, alcohol use, and self-reported diabetes, adjusted for age and gender. Subclinical TB was defined as microbiologically confirmed TB without symptoms of current cough, fever, night sweats, or weight loss and symptomatic TB with at least one of these symptoms. We assessed heterogeneity using forest plots and I We obtained IPD from 16 national surveys out of 21 national and five sub-national surveys identified (five in Asia and 11 in Africa, N = 740,815). Across surveys, 15.1%-56.7% of TB were subclinical (median: 38.1%). In the multivariable model, current smoking was associated with both subclinical (OR 1.67, 95% CI 1.27-2.40) and symptomatic TB (OR 1.49, 95% CI 1.34-1.66). Self-reported diabetes was associated with symptomatic TB (OR 1.67, 95% CI 1.17-2.40) but not with subclinical TB (OR 0.92, 95% CI 0.55-1.55). For alcohol drinking ≥ twice per week vs no alcohol drinking, the estimates were imprecise (OR 1.59, 95% CI 0.70-3.62) for subclinical TB and OR 1.43, 95% CI 0.59-3.46 for symptomatic TB). For the association between current smoking and symptomatic TB, I Our findings suggest that current smokers are more likely to have both symptomatic and subclinical TB. These individuals can, therefore, be prioritised for intensified screening, such as the use of chest X-ray in the context of community-based screening. People with self-reported diabetes are also more likely to have symptomatic TB, but the association is unclear for subclinical TB. None.
Sections du résumé
Background
UNASSIGNED
Non-communicable diseases (NCDs) and NCD risk factors, such as smoking, increase the risk for tuberculosis (TB). Data are scarce on the risk of prevalent TB associated with these factors in the context of population-wide systematic screening and on the association between NCDs and NCD risk factors with different manifestations of TB, where ∼50% being asymptomatic but bacteriologically positive (subclinical). We did an individual participant data (IPD) meta-analysis of national and sub-national TB prevalence surveys to synthesise the evidence on the risk of symptomatic and subclinical TB in people with NCDs or risk factors, which could help countries to plan screening activities.
Methods
UNASSIGNED
In this systematic review and IPD meta-analysis, we identified eligible prevalence surveys in low-income and middle-income countries that reported at least one NCD (e.g., diabetes) or NCD risk factor (e.g., smoking, alcohol use) through the archive maintained by the World Health Organization and by searching in Medline and Embase from January 1, 2000 to August 10, 2021. The search was updated on March 23, 2023. We performed a one-stage meta-analysis using multivariable multinomial models. We estimated the proportion of and the odds ratio for subclinical and symptomatic TB compared to people without TB for current smoking, alcohol use, and self-reported diabetes, adjusted for age and gender. Subclinical TB was defined as microbiologically confirmed TB without symptoms of current cough, fever, night sweats, or weight loss and symptomatic TB with at least one of these symptoms. We assessed heterogeneity using forest plots and I
Findings
UNASSIGNED
We obtained IPD from 16 national surveys out of 21 national and five sub-national surveys identified (five in Asia and 11 in Africa, N = 740,815). Across surveys, 15.1%-56.7% of TB were subclinical (median: 38.1%). In the multivariable model, current smoking was associated with both subclinical (OR 1.67, 95% CI 1.27-2.40) and symptomatic TB (OR 1.49, 95% CI 1.34-1.66). Self-reported diabetes was associated with symptomatic TB (OR 1.67, 95% CI 1.17-2.40) but not with subclinical TB (OR 0.92, 95% CI 0.55-1.55). For alcohol drinking ≥ twice per week vs no alcohol drinking, the estimates were imprecise (OR 1.59, 95% CI 0.70-3.62) for subclinical TB and OR 1.43, 95% CI 0.59-3.46 for symptomatic TB). For the association between current smoking and symptomatic TB, I
Interpretation
UNASSIGNED
Our findings suggest that current smokers are more likely to have both symptomatic and subclinical TB. These individuals can, therefore, be prioritised for intensified screening, such as the use of chest X-ray in the context of community-based screening. People with self-reported diabetes are also more likely to have symptomatic TB, but the association is unclear for subclinical TB.
Funding
UNASSIGNED
None.
Identifiants
pubmed: 37680950
doi: 10.1016/j.eclinm.2023.102191
pii: S2589-5370(23)00368-1
pmc: PMC10480554
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102191Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MC_UU_00004/06
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00004/07
Pays : United Kingdom
Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
TSo declares a receipt of funding from the Global Fund for conducting the TB prevalence survey in Mongolia. All other authors declare no competing interests.
Références
J Health Popul Nutr. 2022 Mar 2;41(1):7
pubmed: 35236427
BMC Public Health. 2015 Oct 16;15:1059
pubmed: 26475303
Trop Med Infect Dis. 2021 Jan 08;6(1):
pubmed: 33435609
Int J Tuberc Lung Dis. 2020 Apr 1;24(4):367-375
pubmed: 32317059
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
Trop Med Int Health. 2018 Oct;23(10):1058-1070
pubmed: 30062731
PLoS One. 2020 Apr 23;15(4):e0232142
pubmed: 32324806
Int J Epidemiol. 2011 Apr;40(2):417-28
pubmed: 21252210
PLoS One. 2013 Dec 18;8(12):e82660
pubmed: 24367535
BMJ Open. 2015 Apr 14;5(4):e006633
pubmed: 25872937
Clin Infect Dis. 2021 Aug 2;73(3):e830-e841
pubmed: 32936877
Int J Tuberc Lung Dis. 2011 Jul;15(7):982-4
pubmed: 21682976
PLoS One. 2021 Oct 5;16(10):e0247245
pubmed: 34610012
Am J Public Health. 2016 Jan;106(1):74-8
pubmed: 26696288
Clin Infect Dis. 2022 Sep 14;75(5):842-848
pubmed: 34984431
PLoS One. 2017 Nov 21;12(11):e0187967
pubmed: 29161276
Int J Tuberc Lung Dis. 2020 Mar 1;24(3):340-346
pubmed: 32228765
Public Health. 2020 Oct;187:24-35
pubmed: 32889229
BMC Public Health. 2019 Mar 12;19(1):295
pubmed: 30866870
Am J Epidemiol. 2012 Oct 15;176(8):738-43
pubmed: 23013620
JAMA. 2015 Apr 28;313(16):1657-65
pubmed: 25919529
PLoS One. 2015 Apr 23;10(4):e0124260
pubmed: 25905900
Cochrane Database Syst Rev. 2022 Mar 23;3:CD010890
pubmed: 35320584
PLoS Med. 2007 Jan;4(1):e20
pubmed: 17227135
PLoS One. 2016 Jan 11;11(1):e0146876
pubmed: 26752596